Search

everythinglearnresearchcommunity

for

Search:↓

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Finasteride is effective and safe for treating hidradenitis suppurativa in both adults and some younger patients.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The guide helps dermatologists diagnose and treat different types of hair loss.

STK11 gene polymorphism does not predict metformin response in PCOS.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Lasers and intense pulsed light can safely and effectively remove hair by targeting hair follicles.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.